Entering text into the input field will update the search result below

IsoRay reports FQ1 results

Nov. 08, 2016 11:48 PM ETPerspective Therapeutics, Inc. (CATX) StockBy: Gaurav Batavia, SA News Editor
  • IsoRay (NYSE:ISR): FQ1 operating loss of $1.5M
  • Revenue of $1.08M (-14.3% Y/Y)
  • Press Release

Recommended For You

More Trending News

About CATX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CATX--
Perspective Therapeutics, Inc.